2011
DOI: 10.1371/journal.pone.0018438
|View full text |Cite
|
Sign up to set email alerts
|

Uremic Toxins Inhibit Transport by Breast Cancer Resistance Protein and Multidrug Resistance Protein 4 at Clinically Relevant Concentrations

Abstract: During chronic kidney disease (CKD), there is a progressive accumulation of toxic solutes due to inadequate renal clearance. Here, the interaction between uremic toxins and two important efflux pumps, viz. multidrug resistance protein 4 (MRP4) and breast cancer resistance protein (BCRP) was investigated. Membrane vesicles isolated from MRP4- or BCRP-overexpressing human embryonic kidney cells were used to study the impact of uremic toxins on substrate specific uptake. Furthermore, the concentrations of various… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
110
1
2

Year Published

2012
2012
2022
2022

Publication Types

Select...
9
1

Relationship

3
7

Authors

Journals

citations
Cited by 119 publications
(119 citation statements)
references
References 35 publications
3
110
1
2
Order By: Relevance
“…In this regard, it has been shown that PCG per se has no effect on leukocyte oxidative burst activity, whereas it may induce a synergistic activating effect in the presence of PCS (12). In addition, the effect of PCG on proximal tubular cells is equivocal (25,26). Additional research is required to elucidate the relevance of a decrease in sulfotransferase activity in patients with advanced CKD with respect to phase 2 metabolism of p-cresol and possibly, also endogenous and drug metabolism in general.…”
Section: Discussionmentioning
confidence: 99%
“…In this regard, it has been shown that PCG per se has no effect on leukocyte oxidative burst activity, whereas it may induce a synergistic activating effect in the presence of PCS (12). In addition, the effect of PCG on proximal tubular cells is equivocal (25,26). Additional research is required to elucidate the relevance of a decrease in sulfotransferase activity in patients with advanced CKD with respect to phase 2 metabolism of p-cresol and possibly, also endogenous and drug metabolism in general.…”
Section: Discussionmentioning
confidence: 99%
“…This is in line with the increasing recognition of the role of tubulo-interstitium in the pathophysiology of renal disease and, accordingly, the notion that an integrative measure of both glomerular and tubular function may bear more prognostic relevance than a specific measure for GFR only (42). Considering the substrate polyspecificity of OCT2 (59), reduced tubular secretion of various candidate substances might potentially be involved, including catecholamines, dopamine, prostaglandins, advanced glycation end products, and, possibly, uremic toxins, that could affect the kidney either directly or by effects on blood pressure and volume status and hence promote progressive renal damage (16,20,28,32,56,60). Finally, the association with ESRD as indicator for the susceptibility to renal damage is corroborated by recent GWAS data reporting a suggestive association between rs316019 and diabetic nephropathy (43).…”
Section: Discussionmentioning
confidence: 99%
“…Both are involved in urinary secretion of urate (36,86), a uremic toxin responsible for the pathogenesis of gout and cardiovascular disease. The interaction of the uremic retention solutes hippuric acid, indoxyl sulfate and kynurenic acid with MRP4 and BCRP, and of indole-3-acetic acid and phenylacetic acid with MRP4 only was recently demonstrated (87). The inhibition of transport by the uremic toxins occurred at clinically relevant concentrations, suggesting that this mechanism may contribute to the progression and the many complications of CKD.…”
Section: Chronic Renal Failurementioning
confidence: 99%